MiRNA assays in the clinical laboratory: Workflow, detection technologies and automation aspects

86Citations
Citations of this article
105Readers
Mendeley users who have this article in their library.

Abstract

microRNAs (miRNAs) are short non-coding RNA molecules that regulate gene expression in eukaryotes. Their differential abundance is indicative or even causative for a variety of pathological processes including cancer or cardiovascular disorders. Due to their important biological function, miRNAs represent a promising class of novel biomarkers that may be used to diagnose life-threatening diseases, and to monitor disease progression. Further, they may guide treatment selection or dosage of drugs. miRNAs from blood or derived fractions are particularly interesting candidates for routine laboratory applications, as they can be measured in most clinical laboratories already today. This assures a good accessibility of respective tests. Albeit their great potential, miRNA-based diagnostic tests have not made their way yet into the clinical routine, and hence no standardized workflows have been established to measure miRNAs for patients' benefit. In this review we summarize the detection technologies and workflow options that exist to measure miRNAs, and we describe the advantages and disadvantages of each of these options. Moreover, we also provide a perspective on data analysis aspects that are vital for translation of raw data into actionable diagnostic test results.

Cite

CITATION STYLE

APA

Kappel, A., & Keller, A. (2017, May 1). MiRNA assays in the clinical laboratory: Workflow, detection technologies and automation aspects. Clinical Chemistry and Laboratory Medicine. Walter de Gruyter GmbH. https://doi.org/10.1515/cclm-2016-0467

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free